MarketCap
Facebook
X
TelegramMediWound Ltd. Gesamtverbindlichkeiten | MDWD
Gesamtverbindlichkeiten Jährlich MediWound Ltd.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 23.8 M | 25.4 M | 26.3 M | 34.5 M | 28 M | 29 M | 28.2 M | 34.6 M | 9.8 M | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 34.6 M | 9.8 M | 26.6 M |
Gesamtverbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Spero Therapeutics
SPRO
|
9.9 M | $ 1.01 | -5.61 % | $ 56.6 M |  USA |
 |
Sarepta Therapeutics
SRPT
|
2.21 B | $ 16.4 | -5.54 % | $ 1.64 B | USA |
 |
Tarsus Pharmaceuticals
TARS
|
219 M | $ 73.9 | 4.32 % | $ 3.09 B | USA |
 |
Bio-Techne Corporation
TECH
|
719 M | $ 72.83 | -0.01 % | $ 11.4 B | USA |
 |
Sage Therapeutics
SAGE
|
82.1 M | - | - | $ 527 M | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
405 M | - | - | $ 1.62 B |  Israel |
 |
Cabaletta Bio
CABA
|
53 M | $ 1.43 | -5.0 % | $ 144 M | USA |
 |
Forma Therapeutics Holdings
FMTX
|
62.7 M | - | - | $ 958 M | USA |
 |
Blueprint Medicines Corporation
BPMC
|
881 M | - | - | $ 8.14 B | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
2.25 B | - | - | $ 26.6 B |  Irlanda |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
32 M | $ 4.12 | -8.35 % | $ 35.1 M | USA |
 |
Paratek Pharmaceuticals
PRTK
|
344 M | - | - | $ 121 M | USA |
 |
DBV Technologies S.A.
DBVT
|
64.9 M | $ 11.55 | 4.52 % | $ 1.61 B |  France |
 |
Gilead Sciences
GILD
|
39 B | $ 170.68 | 0.8 % | $ 212 B | USA |
 |
Taysha Gene Therapies
TSHA
|
96.4 M | $ 4.28 | -2.06 % | $ 1.37 B | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
37.9 M | - | -14.27 % | $ 1.7 M |  Singapore |
 |
Adverum Biotechnologies
ADVM
|
109 M | - | - | $ 86.2 M | USA |
 |
Unity Biotechnology
UBX
|
31.2 M | - | -33.41 % | $ 3.37 M | USA |
 |
iTeos Therapeutics
ITOS
|
96.7 M | - | - | $ 411 M | USA |
 |
Gossamer Bio
GOSS
|
295 M | $ 11.2 | 5.21 % | $ 2.56 B | USA |
 |
GeoVax Labs
GOVX
|
2.52 M | $ 0.11 | -22.17 % | $ 105 K | USA |
 |
United Therapeutics Corporation
UTHR
|
784 M | $ 588.33 | 1.01 % | $ 26.1 B | USA |
 |
Seelos Therapeutics
SEEL
|
38.9 M | - | -47.76 % | $ 6.27 M | USA |
 |
Vericel Corporation
VCEL
|
133 M | $ 59.02 | 1.08 % | $ 2.97 B | USA |
 |
Veracyte
VCYT
|
96.4 M | $ 24.05 | -7.21 % | $ 1.89 B | USA |
 |
Advaxis
ADXS
|
2.3 M | - | -9.65 % | $ 45.9 M | USA |
 |
GlaxoSmithKline plc
GSK
|
45.2 B | $ 51.25 | -0.56 % | $ 208 B |  Britain |
 |
Vir Biotechnology
VIR
|
238 M | $ 13.17 | -3.48 % | $ 1.82 B | USA |
 |
Viking Therapeutics
VKTX
|
76.7 M | $ 28.67 | -1.1 % | $ 3.23 B | USA |
 |
Vanda Pharmaceuticals
VNDA
|
162 M | $ 4.07 | -0.49 % | $ 240 M | USA |
 |
Verrica Pharmaceuticals
VRCA
|
22.4 M | $ 3.55 | -1.11 % | $ 37.8 M | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
6.98 B | $ 547.74 | -0.57 % | $ 140 B | USA |
 |
Kiromic BioPharma
KRBP
|
21.1 M | - | 6.61 % | $ 3.08 M | USA |
 |
vTv Therapeutics
VTVT
|
25.5 M | $ 20.88 | -1.42 % | $ 83.8 M | USA |
 |
CNS Pharmaceuticals
CNSP
|
4.1 M | $ 3.81 | -3.3 % | $ 1.69 M | USA |
 |
Voyager Therapeutics
VYGR
|
56.2 M | $ 1.82 | -8.54 % | $ 107 M | USA |
 |
Calithera Biosciences
CALA
|
8.28 M | - | -10.95 % | $ 876 K | USA |
 |
Applied Molecular Transport
AMTI
|
46.6 M | - | - | $ 10.1 M | USA |
 |
Wave Life Sciences Ltd.
WVE
|
112 M | $ 3.41 | -2.01 % | $ 575 M | Singapore |
 |
Molecular Templates
MTEM
|
31.2 M | - | -23.43 % | $ 495 K | USA |
 |
Exicure
XCUR
|
10.1 M | $ 1.08 | 21.31 % | $ 6.8 M | USA |
 |
Immunome
IMNM
|
48.8 M | $ 18.65 | -3.67 % | $ 1.63 B | USA |
 |
Xeris Pharmaceuticals
XERS
|
370 M | $ 15.81 | -0.35 % | $ 2.54 B | USA |
 |
X4 Pharmaceuticals
XFOR
|
104 M | $ 3.24 | -2.7 % | $ 137 M | USA |
 |
Xencor
XNCR
|
240 M | $ 39.42 | 2.16 % | $ 2.93 B | USA |
 |
INmune Bio
INMB
|
8.83 M | $ 1.09 | -3.54 % | $ 27 M | USA |
 |
Insmed Incorporated
INSM
|
1.53 B | $ 119.55 | 2.97 % | $ 23.8 B | USA |
 |
Ionis Pharmaceuticals
IONS
|
3.03 B | $ 28.02 | -9.63 % | $ 4.48 B | USA |
 |
BioXcel Therapeutics
BTAI
|
140 M | $ 0.07 | 9.81 % | $ 855 K | USA |
 |
InflaRx N.V.
IFRX
|
13.7 M | $ 1.21 | -7.63 % | $ 81.4 M |  Germany |